LGC · 3 hours ago
Senior Scientist I, Analytical Development
LGC Axolabs is a leading provider of CRO / CDMO capability to the therapeutic oligonucleotide discovery and development industry. The Senior Scientist I, Analytical Development will serve as a subject matter expert in analytical method development and validation, leading initiatives and providing technical guidance to ensure compliance with regulatory standards in the characterization and testing of oligonucleotide API and raw materials.
BiotechnologyGeneticsLife Science
Responsibilities
Serve as a subject matter expert (SME) in analytical HPLC method development and validation for oligonucleotide APIs and raw materials
Independently design, execute, and interpret complex analytical studies, including forced degradation, MS/MS sequencing, and stability studies
Lead technical discussions with internal teams and clients to define analytical strategies, troubleshoot challenges, and drive project deliverables
Author and review technical documentation, including method development reports, validation protocols, Standard Operating Procedures (SOPs), and regulatory submission materials
Collaborate with cross-functional teams (e.g., Process Development, Quality Control, and Manufacturing) to integrate analytical solutions into oligonucleotide production workflows
Maintain working knowledge of relevant regulatory and pharmacopeia guidelines (FDA/ICH/USP) to ensure compliance across analytical activities
Provide mentorship and technical guidance to junior scientists, supporting skill development and scientific excellence within the team
Qualification
Required
Bachelor's degree in Chemistry, Biology, Biochemistry, or related discipline with 7+ years of applicable experience, or Master's degree with 5+ years, or Ph.D. with 0–3 years of experience in a related field
Advanced technical understanding of oligonucleotide manufacturing processes and hands-on experience with relevant analytical techniques (i.e. HPLC-MS, GC-FID, etc) and equipment
Working knowledge of chromatography and/or other software including ChemDraw, JMP, Empower, MassLynx, Chromeleon, and/or Waters Connect
Prior experience in a GMP-regulated environment within a CMO/CDMO or pharmaceutical manufacturing setting
Self-starter with strong problem-solving skills and the ability to work independently and collaboratively within cross-functional teams
Strong communication skills, both written and verbal, to effectively present data and collaborate with internal teams and external partners
Ability to manage multiple analytical projects simultaneously while maintaining attention to detail and deliverable timelines
Demonstrated commitment to scientific excellence and alignment with LGC's core values and quality standards
Benefits
Competitive compensation with strong bonus program
Comprehensive medical, dental, and vision benefits for employees and dependents
FSA/HSA Pre-tax savings plans for health care, childcare, and elder care
Deductible Buffer Insurance and Critical Illness Insurance
401(k) retirement plan with matching employer contribution
Company-paid short- and long- term disability, life insurance, and employee assistance program
Flexible work options
Pet Insurance for our furry friends
Enhanced Parental leave of 8 additional weeks
PTO that begins immediately
Town Hall monthly meeting onsite/virtual, Cheer program where employees are recognized for outstanding work, Company wide social events, frequent catered lunches and much more!
Company
LGC
We are a global leader in life science tools, partnering with customers to find solutions that diagnose, treat, feed and protect our growing population.
H1B Sponsorship
LGC has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
Funding
Current Stage
Late StageTotal Funding
unknown2019-11-21Acquired
Recent News
2025-10-22
2025-10-22
Company data provided by crunchbase